Latest Breaking News On - நிடின் ஜோஷி - Page 1 : vimarsana.com

CAGE Bio Initiates Phase 2 Study for Treatment of Rosacea News provided by Share this article Share this article SAN CARLOS, Calif., May 11, 2021 /PRNewswire/  CAGE Bio Inc., a biotechnology company focused on developing innovative therapies for infection, inflammation and immunology, announced dosing of the first patient in its Phase 2 clinical trial for the treatment of inflammatory lesions of rosacea. The 12-week randomized double-blind vehicle-controlled trial is testing CAGE Bio s novel ionic-liquid based product CGB-400 Topical Gel. Patients diagnosed with moderate to severe rosacea with inflammatory lesions on their face will be enrolled in the study at four sites in the US and randomized to an active or vehicle arm.

United statesSan carlosNitin joshiSanta barbaraPerryd chlanJustin koSamir mitragotriUniversity of californiaWyss instituteNational rosacea societyBio incStanford health careProfessor samir mitragotriHansjorg wyss professorBiologically inspired engineeringApplied sciences